TD Asset Management
RNAM

TD Asset Management’s Avidity Biosciences RNAM Stock Holding History

TD Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-457,172
Closed -$19.9M – 1285
2025
Q3 		$19.9M Buy
457,172
+52,776
+13% +$2.13M 0.02% 510
2025
Q2 		$11.5M Sell
404,396
-28,746
-7% -$857K 0.01% 609
2025
Q1 		$12.8M Buy
433,142
+17,970
+4% +$560K 0.01% 586
2024
Q4 		$12.1M Sell
415,172
-19,800
-5% -$827K 0.01% 614
2024
Q3 		$18.4M Sell
434,972
-78,366
-15% -$3.4M 0.02% 526
2024
Q2 		$21M Buy
513,338
+300,054
+141% +$8.61M 0.02% 487
2024
Q1 		$5.44M Sell
213,284
-54,448
-20% -$853K 0.01% 756
2023
Q4 		$2.42M Hold
267,732
– – ﹤0.01% 944
2023
Q3 		$1.71M Buy
267,732
+133,866
+100% +$1.15M ﹤0.01% 1002
2023
Q2 		$1.48M Sell
133,866
-18,702
-12% -$235K ﹤0.01% 1036
2023
Q1 		$2.34M Sell
152,568
-11,847
-7% -$261K ﹤0.01% 936
2022
Q4 		$3.65M Buy
164,415
+31,144
+23% +$464K ﹤0.01% 824
2022
Q3 		$2.23M Buy
133,271
+800
+0.6% +$15.3K ﹤0.01% 970
2022
Q2 		$1.93M Sell
132,471
-10,615
-7% -$158K ﹤0.01% 1017
2022
Q1 		$2.64M Sell
143,086
-5,258
-4% -$89.3K ﹤0.01% 1001
2021
Q4 		$3.53M Buy
148,344
+44,769
+43% +$1.07M ﹤0.01% 970
2021
Q3 		$2.55M Buy
103,575
+75,627
+271% +$1.64M ﹤0.01% 1013
2021
Q2 		$540K Hold
27,948
– – ﹤0.01% 1373
2021
Q1 		$610K Buy
27,948
+4,739
+20% +$116K ﹤0.01% 1367
2020
Q4 		$592K Buy
23,209
+1,600
+7% +$46.7K ﹤0.01% 1302
2020
Q3 		$608K Buy
21,609
+1,300
+6% +$37.6K ﹤0.01% 1196
2020
Q2 		$574K Buy
+20,309
New +$586K ﹤0.01% 1183

Other funds holding RNAM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TD Asset Management's RNAM Position: Q4 2025 in Review

TD Asset Management sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 457,172 shares — an estimated $19.9M sold.

TD Asset Management first reported a position in RNAM in Q2 2020 and held it in 22 quarters. The position peaked at $21M in Q2 2024. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • TD Asset Management reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
  • TD Asset Management sold 457,172 Avidity Biosciences shares in Q4 2025, an estimated $19.9M.
  • TD Asset Management first reported a position in Avidity Biosciences in Q2 2020 and held it in 22 quarters.
  • TD Asset Management's Avidity Biosciences position peaked at $21M in Q2 2024.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on TD Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.